Serum anti-Escherichia coli antibodies and urinary beta-glucuronidase for the diagnosis and control of evolution of urinary infection during pregnancy.
D000372:Agglutination Tests; D000907:Antibodies, Bacterial / Q000032:analysis*; D001437:Bacteriuria / Q000175:diagnosis; D004926:Escherichia coli / Q000276:immunology*; D004927:Escherichia coli Infections / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D005966:Glucuronidase / Q000652:urine*; D006801:Humans; D007231:Infant, Newborn; D009582:Nitrofurantoin / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis* / Q000188:drug therapy; D011704:Pyelonephritis / Q000175:diagnosis / Q000188:drug therapy; D013444:Sulfisoxazole / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000175:diagnosis* / Q000188:drug therapy
D000907:Antibodies, Bacterial; D013444:Sulfisoxazole; D009582:Nitrofurantoin; D005966:Glucuronidase